Nitrendipine-induced subacute cutaneous lupus erythematosus

European Journal of Dermatology

Volumn 13, Issue 2, 2003, Pages 213-216

  Marzano, Angelo V ^a   Borghi, Alessandro ^a   Mercogliano, Maurizio ^a   Facchetti, Maura ^a   Caputo, Ruggero ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Antiphospholipid syndrome; Drug induced subacute cutaneous lupus erythematosus; Nitrendipine

Indexed keywords

ANTINUCLEAR ANTIBODY; CALCIUM CHANNEL BLOCKING AGENT; CARDIOLIPIN ANTIBODY; HISTONE ANTIBODY; LUPUS ANTICOAGULANT; NITRENDIPINE; PHOSPHOLIPID ANTIBODY;

AGED; ANTIHYPERTENSIVE THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; HEMIPARESIS; HUMAN; HUMAN TISSUE; HYPERTENSION; MALE; PHYSICAL EXAMINATION; PROTHROMBIN TIME; SKIN LUPUS ERYTHEMATOSUS; SKIN MANIFESTATION; THROMBOCYTOPENIA; TREATMENT OUTCOME;

AGED; AUTOANTIBODIES; CALCIUM CHANNEL BLOCKERS; HUMANS; LUPUS ERYTHEMATOSUS, CUTANEOUS; MALE; NITRENDIPINE; PARESIS;

EID: 0037357937     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Pramatarov KD. Drug-induced lupus erythematosus. Clin Dermatol 1998; 16: 367-77.
2. Callen JP. Drug-induced cutaneous lupus erythematosus a distinct syndrome that is frequently unrecognized. J Am Acad Dermatol 2001; 45: 315-6.
3. Bonsmann G, Schiller M, Luger TA, Ständer S. Terbinafine-induced subacute cutaneous lupus erythematosus. J Am Acad Dermotol 2001; 44: 925-31.
4. Crowson AN, Magro C. The cutaneous pathology of lupus erythematosus: a review. J Cutan Pathol 2001; 28: 1-23.
5. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002; 346: 752-63.
6. Wallach HW. Lupus-like syndrome associated with carcinoma of the breast. Arch Intern Med 1977; 137; 532-5.
7. Chtourou M, Aubin F, Savariault I, Chabot P, Manchet G, Montcuquet P, Humbert P. Digital necrosis and lupus-like syndrome preceding ovarian carcinoma. Dermatology 1998; 196: 348-9.
8. Strickland RW, Limmani A, Wall JG, Krishnan J. Hairy cell leukemia presenting as a lupus-like illness. Arthritis Rheum 1988; 31: 566-8.
9. Segev A, Hadari R, Zehavi T, Schneider M, Hershkoviz R, Mekori YA. Lupus-like syndrome with submassive hepatic necrosis associated with hepatitis A. J Gastroenterol Hepatol 2001; 16: 112-4.
10. Berman A, Reboredo G, Spindler A, Lasala ME, Lopez H, Espinoza LR. Rheumatic manifestations in populations at risk for HIV infection: the added effect of HIV. J Rheumatol 1991; 18: 1564-7.
11. Dragon-Durey MA, Quartier P, Fremeaux-Bacchi V, Blouin J, de Barace C, Prieur AM, Weiss L, Fridman WH. Molecular basis of a selective C 1 s deficiency associated with early onset multiple autoimmune diseases. J Immunol 2001; 166: 7612-6.
12. Hess E. Drug-related lupus. N Engl J Med 1988; 318: 1460-2.
13. Sontheimer RD, Thomas JR, Gilliam JN. Subacute cutaneous lupus erythematosus. Arch Dermatol 1979; 115: 1409-15.
14. Reed BR, Huff JC, Jones SK, Orton PW, Lee LA, Norris DA. Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy. Ann Intern Med 1985; 103: 49-51.
15. Fernandez-Diaz ML, Herranz P, Suarez-Marrero MC, Borbujo J, Mannaro R, Casado M. Subacute cutaneous lupus erythematosus associated with cilazapril. Lancet 1995; 345: 398.
16. Toll A, Campo-Pisa P, Gonzalez-Castro J, Campo-Voegeli A, Azon A, Iranzo P, Lecha M, Herrero C. Subacute cutaneous lupus erythematosus associated with cinnarizine and thiethylperazine therapy. Lupus 1998; 7: 364-6.
17. Wollenberg A, Meurer M. Thiazid-Diuretika-induzierter subakutkutaner Lupus erythematodes. Hautartz 1991; 42: 709-12.
18. Nousari HC, Kimyai-Asadi A, Tausk FA. Subacute cutaneous lupus erythematosus associated with interferon beta - 1a. Lancet 1998; 352: 1825-6.
19. Miyagawa S, Okuchi T, Shiomi Y, Sakamoto K. Subacute cutaneous lupus erythematosus lesions precipitated by griseofulvin. J Am Acad Dermatol 1989; 21: 343-6.
20. Crowson AN, Magro CM. Subacute cutaneous lupus erythematosus arising in the setting of calcium channel blocker therapy. Hum Pathol 1997; 28: 67-73.
21. Stephens CJM. The antiphospholipid syndrome. Clinical correlations, cutaneous features, mechanism of thrombosis and treatment of patients with the lupus anticoagulant and cardiolipin antibodies. Br J Dermatol 1991; 125: 199-210.
22. Asherson RA, Khamashta MA, Gil A, Vazquez JJ, Chan O, Boguley E, Hughes GR. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. Am J Med 1989; 86: 391-9.
23. Alarcón-Segovia D, Delezé M, Oria CV, Sanchez-Guerrero J, Gomez-Pacheco L, Cabiedes J, Fernandez L, Ponce de Leon S. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. Medicine 1989; 68: 353-65.
24. Marzano AV, Berti E, Gasporini G, Coputo R. Lupus erythematosus with ontiphospholipid syndrome and erythema multiforme-like lesions. Br J Dermotol 1999; 141: 720-4.
25. Drouvalakis KA, Buchanan RR. Phospholipid specificity of autoimmune and drug induced lupus anticoagulants; association of phosphatidylethanolamine reactivity with thrombosis in autoimmune disease. J Rheumatol 1998; 25: 290-5.